Pre-seed · Enterprise software
Axio BioPharma raises $2.4 million pre-seed round
The startup is building data connectors and mapping software for pharmaceutical manufacturers coordinating work across company boundaries.
A shared view without moving raw data
Axio Lattice connects pharmaceutical sponsors and manufacturing partners through systems that read from each organization's existing software while keeping raw records within its chosen boundary. Its Rosetta layer maps differing field names, units and process terminology to shared concepts, so collaborators can review a consistent view of production information. The company says its first node is operating at Forward BioLabs as it prepares partner deployments.
Use of funds
Support initial deployments of Axio Lattice
Continue development of Rosetta ontology mapping layer
Funding history
Pre-seed · This round$2.4M